Oxbow Advisors’s Boston Scientific BSX Stock Holding History

Oxbow Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-8,196	Closed	-$433K	–	209
2023 Q3	$433K	Hold	8,196	–	–	0.07%	126
2023 Q2	$443K	Buy	+8,196	New	+$428K	0.07%	137

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Oxbow Advisors's BSX Position: Q4 2023 in Review

Oxbow Advisors sold out of Boston Scientific (BSX) in Q4 2023, closing a stake of 8,196 shares — an estimated $433K sold.

Oxbow Advisors first reported a position in BSX in Q2 2023 and held it in 2 quarters. The position peaked at $443K in Q2 2023. 1,148 funds tracked by Wall St. Rank hold BSX as of Q4 2023.

Oxbow Advisors reported no remaining Boston Scientific position as of Q4 2023 after selling out during the quarter.
Oxbow Advisors sold 8,196 Boston Scientific shares in Q4 2023, an estimated $433K.
Oxbow Advisors first reported a position in Boston Scientific in Q2 2023 and held it in 2 quarters.
Oxbow Advisors's Boston Scientific position peaked at $443K in Q2 2023.
1,148 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2023.

Based on Oxbow Advisors's 13F filing for Q4 2023, filed 8 Feb 2024.